MedTrace Logo

A Study to Evaluate the Safety and Clinical Performance of a Dexpanthenol Medicated Hydrogel Patch in the Treatment of Standardized Superficial Abrasions

NCT07642973 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-06-16

No results posted yet for this study

Summary

Clinical evaluation of a Dexpanthenol-medicated wound plaster on standardized superficial skin abrasions

Conditions

  • Skin Wounds
  • Abrasion

Interventions

DEVICE

hydrogel plaster with dexpanthenol

On the wound will be applied daily an hydrogel plaster with Dexpanthenol

DEVICE

Standard plaster

On the wound will be daily applicated a standard plaster on the market

Sponsors & Collaborators

  • Nextrasearch S.r.l.s.

    collaborator OTHER

  • Wooshin Labottach Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Alessandro Guzzo, MD · la U.O.C. Anestesia Rianimazione degli Ospedali Riuniti Padova Sud con indirizzo via Albere, 30 Monselice

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2026-10-31
Completion
2026-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07642973 on ClinicalTrials.gov